Supply Chain

The FDA approved Luxturna, a first-of-its-kind gene therapy, to treat a rare form of inherited vision loss that can result in complete blindness.

Pfizer's board of directors approved a $10 billion share repurchase program Monday and raised its quarterly dividend, according to CNBC.

The Food and Drug Administration on Monday issued a draft proposal of a new, risk-based enforcement policy to strengthen regulations on homeopathic therapies deemed most likely to pose health threats to consumers.

The FDA proposed a new regulation approach Monday to crack down on the growing number of homeopathic remedies that show no clinical benefit.

Bloodworks Northwest issued an urgent request for blood donors Monday after an Amtrak train derailed outside of Tacoma, Wash. onto a highway, according to The Olympian.

The medical device industry is calling on Congress to pass a delay of the ACA's medical device tax sooner rather than later, according to The Hill.

Drchrono — a provider of iPhone-based EMR, practice management and healthcare application programming interface platforms — partnered with the medical inventory management provider FlexScanMD, the companies announced Dec. 14.

Two months following the FDA's approval of Gilead Science's breakthrough lymphoma treatment, only five patients have received the expensive therapy, according to Bloomberg.

Teva Pharmaceutical Industries, which is grappling with $35 billion of debt, announced plans Thursday to cut 14,000 jobs worldwide and consolidate six of its seven U.S. sites into one location, according to USA Today.

Drugs to treat "neglected tropical diseases," like many intestinal parasites, are extraordinarily expensive in the U.S. compared to other places in the world, according to a report from NPR.